124 related articles for article (PubMed ID: 2973416)
1. Expression of CD23 antigen is not necessary for human 12-kDa B cell growth factor-mediated B cell proliferation.
Vazquez A; Mills S; Sharma S; Maizel AL
Eur J Immunol; 1988 Oct; 18(10):1647-9. PubMed ID: 2973416
[TBL] [Abstract][Full Text] [Related]
2. Low molecular weight B cell growth factor-responsive cloned human B cell lines. I. Phenotypic differences and lack of requirement for CD23 (Fc epsilon RII).
Warrington RJ; Rutherford WJ; Wong SK; Cook JM; Rector ES
J Immunol; 1989 Oct; 143(8):2546-52. PubMed ID: 2529311
[TBL] [Abstract][Full Text] [Related]
3. Regulation by interleukin 2 of CD23 expression of leukemic and normal B cells: comparison with interleukin 4.
Hivroz C; Vallé A; Brouet JC; Banchereau J; Grillot-Courvalin C
Eur J Immunol; 1989 Jun; 19(6):1025-30. PubMed ID: 2526738
[TBL] [Abstract][Full Text] [Related]
4. Cross-linking of CD23 antigen by its natural ligand (IgE) or by anti-CD23 antibody prevents B lymphocyte proliferation and differentiation.
Luo HY; Hofstetter H; Banchereau J; Delespesse G
J Immunol; 1991 Apr; 146(7):2122-9. PubMed ID: 1826018
[TBL] [Abstract][Full Text] [Related]
5. IFN-gamma and prostaglandin E2 inhibit IL-4-induced expression of Fc epsilon R2/CD23 on B lymphocytes through different mechanisms without altering binding of IL-4 to its receptor.
Galizzi JP; Cabrillat H; Rousset F; Ménétrier C; de Vries JE; Banchereau J
J Immunol; 1988 Sep; 141(6):1982-8. PubMed ID: 2844892
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 4 and soluble CD23 as progression factors for human B lymphocytes: analysis of their interactions with agonists of the phosphoinositide "dual pathway" of signalling.
Gordon J; Cairns JA; Millsum MJ; Gillis S; Guy GR
Eur J Immunol; 1988 Oct; 18(10):1561-5. PubMed ID: 2847932
[TBL] [Abstract][Full Text] [Related]
7. Functional implication for the topographical relationship between MHC class II and the low-affinity IgE receptor: occupancy of CD23 prevents B lymphocytes from stimulating allogeneic mixed lymphocyte responses.
Flores-Romo L; Johnson GD; Ghaderi AA; Stanworth DR; Veronesi A; Gordon J
Eur J Immunol; 1990 Nov; 20(11):2465-9. PubMed ID: 2147649
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of anti-IgM and growth factor-induced proliferation of guinea pig B cells by one of two distinct Fc gamma receptors on the cells.
Yamashita T; Koyama J
J Immunol; 1988 Nov; 141(9):2889-94. PubMed ID: 2971734
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Fc receptor for IgE (CD23) and class II MHC antigen expression on Burkitt's lymphoma cell lines by human IL-4 and IFN-gamma.
Rousset F; Malefijt RW; Slierendregt B; Aubry JP; Bonnefoy JY; Defrance T; Banchereau J; de Vries JE
J Immunol; 1988 Apr; 140(8):2625-32. PubMed ID: 2965726
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 4 strongly augments or inhibits DNA synthesis and differentiation of B-type chronic lymphocytic leukemia cells depending on the co-stimulatory activation and progression signals.
Carlsson M; Sundström C; Bengtsson M; Tötterman TH; Rosén A; Nilsson K
Eur J Immunol; 1989 May; 19(5):913-21. PubMed ID: 2525477
[TBL] [Abstract][Full Text] [Related]
11. The Fc epsilon R2/CD23 antigen: a hallmark of chronic lymphocytic leukemia B cells.
Almerigogna F; Biagiotti R; Giudizi MG; Alessi A; Ricci M; Bosi A; Romagnani S
Ric Clin Lab; 1989; 19(2):129-38. PubMed ID: 2528201
[TBL] [Abstract][Full Text] [Related]
12. Human recombinant interleukin 4 induces normal B cells to produce soluble CD23/IgE-binding factor analogous to that spontaneously released by lymphoblastoid B cell lines.
Bonnefoy JY; Defrance T; Peronne C; Menetrier C; Rousset F; Pène J; De Vries JE; Banchereau J
Eur J Immunol; 1988 Jan; 18(1):117-22. PubMed ID: 2831064
[TBL] [Abstract][Full Text] [Related]
13. Recombinant soluble Fc epsilon receptor II (Fc epsilon RII/CD23) has IgE binding activity but no B cell growth promoting activity.
Uchibayashi N; Kikutani H; Barsumian EL; Hauptmann R; Schneider FJ; Schwendenwein R; Sommergruber W; Spevak W; Maurer-Fogy I; Suemura M
J Immunol; 1989 Jun; 142(11):3901-8. PubMed ID: 2523938
[TBL] [Abstract][Full Text] [Related]
14. Functional interaction between B cell subpopulations defined by CD23 expression.
Armitage RJ; Goff LK
Eur J Immunol; 1988 Nov; 18(11):1753-60. PubMed ID: 2974422
[TBL] [Abstract][Full Text] [Related]
15. Intact, 45-kDa (membrane) form of CD23 is consistently mitogenic for normal and transformed B lymphoblasts.
Cairns JA; Gordon J
Eur J Immunol; 1990 Mar; 20(3):539-43. PubMed ID: 2138559
[TBL] [Abstract][Full Text] [Related]
16. Allergen-directed expression of Fc receptors for IgE (CD23) on human T lymphocytes is modulated by interleukin 4 and interferon-gamma.
Prinz JC; Baur X; Mazur G; Rieber EP
Eur J Immunol; 1990 Jun; 20(6):1259-64. PubMed ID: 2142456
[TBL] [Abstract][Full Text] [Related]
17. The marmoset B-lymphoblastoid cell line (B95-8) produces and responds to B-cell growth and differentiation factors: role of shed CD23 (sCD23).
Callard RE; Lau YL; Shields JG; Smith SH; Cairns J; Flores-Romo L; Gordon J
Immunology; 1988 Nov; 65(3):379-84. PubMed ID: 3145248
[TBL] [Abstract][Full Text] [Related]
18. IL-4 counteracts anti-mu-induced human B cell proliferation: involvement of a cAMP-dependent inhibitory pathway.
Taieb J; Leca G; Auffredou MT; Galanaud P; Vazquez A
Eur Cytokine Netw; 1991; 2(4):265-72. PubMed ID: 1721849
[TBL] [Abstract][Full Text] [Related]
19. Soluble CD23 is released by B lymphocytes cycling in response to interleukin 4 and anti-Bp50 (CDw40).
Cairns J; Flores-Romo L; Millsum MJ; Guy GR; Gillis S; Ledbetter JA; Gordon J
Eur J Immunol; 1988 Mar; 18(3):349-53. PubMed ID: 2965643
[TBL] [Abstract][Full Text] [Related]
20. Recombinant 25-kDa CD23 and interleukin 1 alpha promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis.
Liu YJ; Cairns JA; Holder MJ; Abbot SD; Jansen KU; Bonnefoy JY; Gordon J; MacLennan IC
Eur J Immunol; 1991 May; 21(5):1107-14. PubMed ID: 1828027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
